Omicron News and Research

RSS

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

A new study in the journal Clinical Infectious Diseases aimed to determine the relative vaccine effectiveness (rVE) in three different recipient cohorts, those who received the Ad26.COV2.S vaccine followed by Ad26.COV2.S booster, those who received the Ad26.COV2.S vaccine followed by an mRNA booster, and those who received two doses of an mRNA vaccine followed by an mRNA booster.

12 Feb 2023

No new SARS-CoV-2 variants detected in China since COVID policy change

In a recent study published in The Lancet, researchers reported the trends in coronavirus disease 2019 (COVID-19) cases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in Beijing in 2022.

9 Feb 2023

Maternal covid-19 vaccination during pregnancy may reduce risk of hospital admission in infants

Two doses of mRNA covid-19 vaccine during pregnancy are highly effective against delta and moderately effective against omicron infection, and are linked to a lower risk of hospital admission in infants under six months of age, finds a Canadian study published by The BMJ today.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Researchers assess the impact of COVID-19 vaccination on immune responses during a breakthrough infection.

9 Feb 2023

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous vaccination improves the neutralization of SARS-CoV-2 Omicron sub-variants.

9 Feb 2023

Researchers discover small molecules that can lock SARS-CoV-2 spike proteins

The infamous spike proteins on the surface of SARS-CoV-2 help it bind to and enter human cells. Because of their important role in spreading infection, these spike proteins are one of the main targets for COVID-19 vaccines and treatments.

9 Feb 2023

Comparison of pre- and post-Omicron disease severity among unvaccinated people without risk factors

In a recent study posted to the medRxiv* preprint server, researchers in Sweden investigated coronavirus disease 2019 (COVID-19) severity among unvaccinated adults during the periods of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) dominance compared to the severity of pre-Omicron VOC infections.

8 Feb 2023

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Researchers correlate SARS-CoV-2 load and neutralizing capacity of all saliva immunoglobulins isotypes in asymptomatic individuals.

8 Feb 2023

Do individuals with long COVID ever recover fully?

Researchers investigate the sociodemographic factors that contribute to the remission of long COVID.

7 Feb 2023

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers analyzed data from the Increasing Community Access to Testing (ICATT), a nationwide pharmacy program run in the US for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.

7 Feb 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

How did human mobility affect COVID-19 case growth?

A new study posted to the medRxiv* preprint server investigated how human mobility influenced SARS-CoV-2 transmission, based on a network-based approach and panel regression methods.

6 Feb 2023

Detecting novel SARS-CoV-2 variants via rapid RT-PCR assays

A new study on the medRxiv* preprint server assessed whether a novel assay could detect VOCs without substantial reductions in sensitivity.

6 Feb 2023

Virus Watch: A cohort study of COVID-19 in households of England and Wales

A new study posted on the pre-print medRxiv* aimed to discuss how Virus Watch provided public health approaches that were effective for the investigation of community incidence, symptom profiles, and the transmission of COVID-19, as well as the effectiveness of the COVID-19 vaccines.

5 Feb 2023

Omicron News and Research

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

No new SARS-CoV-2 variants detected in China since COVID policy change

Maternal covid-19 vaccination during pregnancy may reduce risk of hospital admission in infants

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Researchers discover small molecules that can lock SARS-CoV-2 spike proteins

Comparison of pre- and post-Omicron disease severity among unvaccinated people without risk factors

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Do individuals with long COVID ever recover fully?

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

How did human mobility affect COVID-19 case growth?

Detecting novel SARS-CoV-2 variants via rapid RT-PCR assays

Virus Watch: A cohort study of COVID-19 in households of England and Wales

Proteomics reveals a distinct IFN-driven plasma cytokine response to COVID-19 in infants and young children

The effectiveness of intranasal COVID-19 vaccination in healthy adults

Where does COVID-19 rank as an underlying cause of death for children and young people in the US?

Establishment of a rapid and accurate SARS-CoV-2 antigen detection kit able to identify Omicron mutants

What is the incidence of COVID-19-associated febrile seizures in children?

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News